Prognosis of SRD Patients in the ICU

University Hospital, Montpellier525 enrolled

Overview

Critically ill systemic rheumatic disease (SRD) patients have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality and most importantly long-term outcome are scarce. The aim of this study is to assess short and long-term outcome of patients with SRD admitted to the ICU in a retrospective cohort study (2006 - 2016).

Study Type

OBSERVATIONAL

Enrollment

525

Conditions

Systemic Rheumatic Diseases Intensive Care Unit Corticosteroids

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion criteria: * All consecutive SRD patients admitted to ICUs during the study period * at least one urine sample Exclusion criteria: * Age \< 18 years * Persons under protection * Paritcipation rejections * Admition to the ICU after scheduled surgery or trauma or suicide attempt unrelated to neurological involvement of SRD * Cancer treated with chemotherapy within a month before ICU admission

Locations (1)

Uhmontpellier

Montpellier, France

Outcomes

Primary Outcomes

Mortality rate in the ICU associated risk factors

Time frame: 1 day

Secondary Outcomes

Mortality rate in the hospital and one-year after ICU admission and associated risk factors

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.